1 Study Coverage

• 1.1 Safety Lancets Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Safety Lancets Market Size Growth Rate by Type
  • 1.4.2 Needle
  • 1.4.3 Blade
• 1.3 Market by Application
  • 1.3.1 Global Safety Lancets Market Size Growth Rate by Application
  • 1.3.2 Hospital and Clinics
  • 1.3.3 Diagnostic Centers
  • 1.3.4 Home Diagnostics
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Safety Lancets Sales Estimates and Forecasts 2016-2027
• 2.2 Global Safety Lancets Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Safety Lancets Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Safety Lancets Regions by Sales
  • 2.4.1 Global Top Safety Lancets Regions by Sales (2016-2021)
  • 2.4.2 Global Top Safety Lancets Regions by Sales (2022-2027)
• 2.5 Global Top Safety Lancets Regions by Revenue
  • 2.5.1 Global Top Safety Lancets Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Safety Lancets Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Safety Lancets Sales by Manufacturers
  • 3.1.1 Global Top Safety Lancets Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Safety Lancets Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Safety Lancets Sales in 2020
• 3.2 Global Safety Lancets Revenue by Manufacturers
  • 3.2.1 Global Top Safety Lancets Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Safety Lancets Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Safety Lancets Revenue in 2020
• 3.3 Global Safety Lancets Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Safety Lancets Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Safety Lancets Sales by Type
  • 4.1.1 Global Safety Lancets Historical Sales by Type (2016-2021)
  • 4.1.2 Global Safety Lancets Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Safety Lancets Sales Market Share by Type (2016-2027)
• 4.2 Global Safety Lancets Revenue by Type
  • 4.2.1 Global Safety Lancets Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Safety Lancets Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Safety Lancets Revenue Market Share by Type (2016-2027)
• 4.3 Global Safety Lancets Price by Type
  • 4.3.1 Global Safety Lancets Price by Type (2016-2021)
  • 4.3.2 Global Safety Lancets Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Safety Lancets Sales by Application
  • 5.1.1 Global Safety Lancets Historical Sales by Application (2016-2021)
  • 5.1.2 Global Safety Lancets Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Safety Lancets Sales Market Share by Application (2016-2027)
• 5.2 Global Safety Lancets Revenue by Application
  • 5.2.1 Global Safety Lancets Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Safety Lancets Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Safety Lancets Revenue Market Share by Application (2016-2027)
• 5.3 Global Safety Lancets Price by Application
  • 5.3.1 Global Safety Lancets Price by Application (2016-2021)
  • 5.3.2 Global Safety Lancets Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Safety Lancets Market Size by Type
  • 6.1.1 North America Safety Lancets Sales by Type (2016-2027)
  • 6.1.2 North America Safety Lancets Revenue by Type (2016-2027)
• 6.2 North America Safety Lancets Market Size by Application
  • 6.2.1 North America Safety Lancets Sales by Application (2016-2027)
  • 6.2.2 North America Safety Lancets Revenue by Application (2016-2027)
• 6.3 North America Safety Lancets Market Size by Country
  • 6.3.1 North America Safety Lancets Sales by Country (2016-2027)
  • 6.3.2 North America Safety Lancets Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Safety Lancets Market Size by Type
  • 7.1.1 Europe Safety Lancets Sales by Type (2017-2027)
  • 7.1.2 Europe Safety Lancets Revenue by Type (2017-2027)
• 7.2 Europe Safety Lancets Market Size by Application
  • 7.2.1 Europe Safety Lancets Sales by Application (2017-2027)
  • 7.2.2 Europe Safety Lancets Revenue by Application (2017-2027)
• 7.3 Europe Safety Lancets Market Size by Country
  • 7.3.1 Europe Safety Lancets Sales by Country (2017-2027)
  • 7.3.2 Europe Safety Lancets Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Safety Lancets Market Size by Type
  • 8.1.1 Asia Pacific Safety Lancets Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Safety Lancets Revenue by Type (2018-2027)
• 8.2 Asia Pacific Safety Lancets Market Size by Application
  • 8.2.1 Asia Pacific Safety Lancets Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Safety Lancets Revenue by Application (2018-2027)
• 8.3 Asia Pacific Safety Lancets Market Size by Region
  • 8.3.1 Asia Pacific Safety Lancets Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Safety Lancets Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Safety Lancets Market Size by Type
  • 9.1.1 Latin America Safety Lancets Sales by Type (2019-2027)
  • 9.1.2 Latin America Safety Lancets Revenue by Type (2019-2027)
• 9.2 Latin America Safety Lancets Market Size by Application
  • 9.2.1 Latin America Safety Lancets Sales by Application (2019-2027)
  • 9.2.2 Latin America Safety Lancets Revenue by Application (2019-2027)
• 9.3 Latin America Safety Lancets Market Size by Country
  • 9.3.1 Latin America Safety Lancets Sales by Country (2019-2027)
  • 9.3.2 Latin America Safety Lancets Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Safety Lancets Market Size by Type
  • 6.1.1 Middle East and Africa Safety Lancets Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Safety Lancets Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Safety Lancets Market Size by Application
  • 6.2.1 Middle East and Africa Safety Lancets Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Safety Lancets Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Safety Lancets Market Size by Country
  • 6.3.1 Middle East and Africa Safety Lancets Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Safety Lancets Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 UAE

11 Company Profiles

• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Safety Lancets Product Description
  • 11.1.5 Roche Related Developments
• 11.2 BD
  • 11.2.1 BD Corporation Information
  • 11.2.2 BD Overview
  • 11.2.3 BD Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 BD Safety Lancets Product Description
  • 11.2.5 BD Related Developments
• 11.3 Bayer
  • 11.3.1 Bayer Corporation Information
  • 11.3.2 Bayer Overview
  • 11.3.3 Bayer Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Bayer Safety Lancets Product Description
  • 11.3.5 Bayer Related Developments
• 11.4 Lifescan
  • 11.4.1 Lifescan Corporation Information
  • 11.4.2 Lifescan Overview
  • 11.4.3 Lifescan Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Lifescan Safety Lancets Product Description
  • 11.4.5 Lifescan Related Developments
• 11.5 B. Braun
  • 11.5.1 B. Braun Corporation Information
  • 11.5.2 B. Braun Overview
  • 11.5.3 B. Braun Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 B. Braun Safety Lancets Product Description
  • 11.5.5 B. Braun Related Developments
• 11.6 Terumo
  • 11.6.1 Terumo Corporation Information
  • 11.6.2 Terumo Overview
  • 11.6.3 Terumo Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Terumo Safety Lancets Product Description
  • 11.6.5 Terumo Related Developments
• 11.7 Nipro
  • 11.7.1 Nipro Corporation Information
  • 11.7.2 Nipro Overview
  • 11.7.3 Nipro Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Nipro Safety Lancets Product Description
  • 11.7.5 Nipro Related Developments
• 11.8 Sarstedt
  • 11.8.1 Sarstedt Corporation Information
  • 11.8.2 Sarstedt Overview
  • 11.8.3 Sarstedt Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Sarstedt Safety Lancets Product Description
  • 11.8.5 Sarstedt Related Developments
• 11.9 ARKRAY
  • 11.9.1 ARKRAY Corporation Information
  • 11.9.2 ARKRAY Overview
  • 11.9.3 ARKRAY Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 ARKRAY Safety Lancets Product Description
  • 11.9.5 ARKRAY Related Developments
• 11.10 Smiths Medical
  • 11.10.1 Smiths Medical Corporation Information
  • 11.10.2 Smiths Medical Overview
  • 11.10.3 Smiths Medical Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Smiths Medical Safety Lancets Product Description
  • 11.10.5 Smiths Medical Related Developments
• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Safety Lancets Product Description
  • 11.1.5 Roche Related Developments
• 11.12 HemoCue
  • 11.12.1 HemoCue Corporation Information
  • 11.12.2 HemoCue Overview
  • 11.12.3 HemoCue Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 HemoCue Product Description
  • 11.12.5 HemoCue Related Developments
• 11.13 Greiner Bio One
  • 11.13.1 Greiner Bio One Corporation Information
  • 11.13.2 Greiner Bio One Overview
  • 11.13.3 Greiner Bio One Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Greiner Bio One Product Description
  • 11.13.5 Greiner Bio One Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Safety Lancets Value Chain Analysis
• 12.2 Safety Lancets Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Safety Lancets Production Mode & Process
• 12.4 Safety Lancets Sales and Marketing
  • 12.4.1 Safety Lancets Sales Channels
  • 12.4.2 Safety Lancets Distributors
• 12.5 Safety Lancets Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Safety Lancets Industry Trends
• 13.2 Safety Lancets Market Drivers
• 13.3 Safety Lancets Market Challenges
• 13.4 Safety Lancets Market Restraints

14 Key Findings in The Global Safety Lancets Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details

Safety Lancets market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Safety Lancets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Needle
Blade

Segment by Application
Hospital and Clinics
Diagnostic Centers
Home Diagnostics
Others

By Company
Roche
BD
Bayer
Lifescan
B. Braun
Terumo
Nipro
Sarstedt
ARKRAY
Smiths Medical
Owen Mumford
HemoCue
Greiner Bio One

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia